INTRODUCTION
Phosphoinositides (PIs) play critical roles in signaling events that occur in specific membrane compartments. At the plasma membrane, PIs can mediate early growth factor responses that lead to cell proliferation or chemotaxis. At endomembranes, PIs can regulate vesicle trafficking events that control endocytosis, exocytosis, or autophagy (1) . The physiological function of phosphatidylinositol 5-monophosphate (PI-5-P) is unclear. Its discovery followed from the biochemical characterization of the enzyme PIP4k (phosphatidylinositol-5-phosphate 4-kinase), which phosphorylates PI-5-P to generate phosphatidylinositol 4,5-bisphosphate [PI(4,5)P 2 ] (2).
The PI-5-P pathway contributes only a small fraction of the total PI(4,5) P 2 in cells (3) . Thus, it has been postulated that PIP4k's main function is to regulate intracellular PI-5-P and/or generate PI(4,5)P 2 on specific membrane compartments where PI-5-P is present (4) . We have reported that PI-5-P is enriched in low-density membrane compartments associated with smooth endoplasmic reticulum (ER) and Golgi, where PIP4k has also been localized (5) , suggesting that these are sites of PI-5-P-mediated PI(4,5)P 2 synthesis. PI(4,5)P 2 regulates membrane trafficking events such as vesicle budding, fusion, and actin rearrangement (4), but evidence for a physiological role for PI-5-P in these events is scarce (6) . Understanding the spatial and temporal regulation of PIP4k will be crucial to establish the physiological function of PI-5-P and of the alternative pathway for PI(4,5)P 2 synthesis.
The PIP4k family is well conserved from worms to mammals, but absent in yeast (6) . Although there is only one gene encoding PIP4k in Drosophila and Caenorhabditis elegans, three distinct isoforms (a, b, and g) have been identified in mammals. All three isoforms of PIP4k have similar protein structure: a C-terminal kinase domain that is interrupted by an insert region and an N-terminal dimerization domain (7) . The a and b isoforms share 83% identity at the protein level, whereas the g isoform only shares 60% identity with either one (7) . In comparison to a and b, the g isoform has poor catalytic activity, and it has been suggested that it serves as a chaperone for the more active isoforms (8) .
Several studies indicate that PIP4k enzymes play a role in cellular signaling events (9) (10) (11) . All three PIP4k isoforms are phosphorylated in response to extracellular cues (3) . The b isoform is phosphorylated by the mitogen-activated protein kinase (MAPK) p38 at Ser 326 in response to stress signals, resulting in attenuation of its kinase activity and subsequent increase in cellular PI-5-P (11) . The a isoform is phosphorylated at Thr 376 by protein kinase D (PKD), a phosphorylation event that inhibits enzyme activity (12) . The g isoform is phosphorylated in response to growth factors (13) , but unlike the a and b isoforms, the effect of phosphorylation and the kinase involved had not been identified.
Here, we examined how PIP4kg regulates signaling downstream of the mTORC1. TORC1 is a nutrient-sensing kinase complex involved in the regulation of protein translation, autophagy, and proliferation in response to amino acid, energy, and growth factors (14) . We found that PIP4kg is a positive regulator of the mTORC1 signal that controls protein translation. First, we show that knockdown of PIP4kg reversed the effect of Tsc2 knockdown on cell mass, resulting in smaller cells. Consistently, PIP4kg knockdown impaired basal mTORC1 activity, as determined by analysis of the phosphorylation of the TORC1 substrates p70S6K (p70S6 kinase) and 4E-BP [eIF4E (eukaryotic initiation factor 4E)-binding protein] in starved cells. Furthermore, we demonstrate that PIP4kg was phosphorylated by mTORC1 in a manner dependent on nutrient availability. Two serine residues in the kinase insert region of PIP4kg were identified as mTORC1-dependent phosphorylation sites. Using subcellular fractionation, we found that the unphosphorylated form of PIP4kg predominantly localized in Golgiassociated vesicles, whereas the phosphorylated forms were enriched in cytosolic vesicles. mTORC1 signaling was enhanced by expression of wild-type or phosphorylation-defective mutant of PIP4kg and decreased by that of a phosphorylation-mimetic mutant. Together, these results demonstrate that in its unphosphorylated form, PIP4kg is necessary to maintain basal mTORC1 activity and that upon nutrient stimulation, mTORC1 phosphorylates and shuts down this function of PIP4kg.
RESULTS

PIP4kg stimulates mTORC1 signaling
A cellular response to TORC1 activation is an increase in the rate of protein translation that leads to an increase in cell mass (15) . Drosophila that express a loss-of-function mutant of dPIP4k have smaller cells and delayed larval development due to impaired TORC1 signaling (16) . To investigate whether PIP4kg plays a role in mTORC1 signaling in mammalian cells, we used short hairpin RNA (shRNA) to stably knock down PIP4kg expression in HeLa cells in which mTORC1 was constitutively activated due to knockdown of its inhibitor Tsc2 (17, 18) . When compared to control cells, serum-starved Tsc2 knockdown cells had increased phosphorylation of S6 (Fig. 1A , compare lanes 1 and 2), consistent with Tsc2 knockdown. We examined the effect of PIP4kg knockdown on cell size by measuring changes in the low-angle forward light scatter (FSC-H) with a flow cytometer. Changes in FSC-H are directly proportional to the diameter of the cell. When compared to control cells, serum-starved Tsc2 knockdown cells had a distinct shift to the right in FSC-H (fig. S1A, upper left panel), indicating increased cell size. Knockdown of Tsc2 resulted in a 5% increase, and 24-hour rapamycin treatment resulted in a 3% decrease in mean FSC-H as compared to control cells (Fig. 1B) . These are comparable to the previously reported 4% reduction in mean FSC-H in HeLa cells treated with rapamycin for 72 hours (19) . Knockdown of PIP4kg in serum-starved Tsc2 knockdown cells decreased PIP4kg abundance by 80 to 90% (Fig. 1A) and reduced cell mass, as demonstrated by a shift in FSC-H distribution as compared to control cells (fig. S1A, bottom right panel) and a 4% reduction in the mean FSC-H (Fig. 1B) . This significant reduction in cell size is comparable to the 3% reduction in cell diameter in 293 cells with mTOR knockdown (20) . These results suggested that mTORC1 signaling is impaired in PIP4kg knockdown cells.
To better understand the role of PIP4kg in mTORC1-mediated regulation of cell mass, we examined whether PIP4kg knockdown affected mTORC1-mediated signals that regulate protein translation. mTORC1 activation by amino acids, glucose, and growth factors leads to phosphorylation of the ribosomal S6 subunit through activation of p70S6K. mTORC1 also phosphorylates the translation inhibitor 4E-BP (eIF4E-binding protein). In its unphosphorylated form, 4E-BP binds to eIF4E on mRNAs with 5′ caps to prevent assembly of the translation initiation complex (21) . TORC1-dependent phosphorylation of 4E-BP leads to its dissociation from eIF4E to allow recruitment of eIF4G, formation of the initiation complex, and translation initiation. We examined the effect of PIP4kg knockdown on the phosphorylation of p70S6K and S6 using phosphorylation-specific antibodies, and on the amounts of unphosphorylated 4E-BP using either an antibody specific to the unphosphorylated form of 4E-BP (anti-nonphospho-4E-BP) or m7GTP pulldown assays. m7GTP-Sepharose beads can specifically pull down the unphosphorylated form of 4E-BP associated with eIF4E by mimicking CAP-containing mRNA (22) . Cells with complete depletion of Tsc2 have high TORC1 activity and are insensitive to serum starvation (18) . mTORC1 signaling was slightly decreased by serum starvation in Tsc2 knockdown cells (Fig. 1C, compare lanes 1 and 2,  and fig. S1B ), which is likely due to residual Tsc2 expression. As expected, short-term treatment of these cells with rapamycin completely inhibited S6 phosphorylation and increased the abundance of unphosphorylated 4E-BP and eIF4E-associated 4E-BP (Fig. 1C ) due to inhibition of TORC1. Knockdown of PIP4kg in serum-starved HeLa cells with Tsc2 knockdown decreased the phosphorylation of S6 and p70S6K, and increased the association of 4E-BP with eIF4E and the amount of unphosphorylated 4E-BP (Fig. 1 , A, C, and D, and fig. S1B ). These results confirmed that PIP4kg knockdown decreased signaling downstream of TORC1 and are consistent with the decrease in cell size.
We compared the effect of PIP4kg knockdown on mTORC1 signaling in cells growing in complete medium or in medium lacking amino acids or glucose and glutamine. As expected, amino acid starvation of control cells almost completely inhibited the phosphorylation of p70S6K and increased the abundance of unphosphorylated 4E-BP [ Fig. 1 , E (lanes 7 and 8) and F (gray bars)]. In contrast, Tsc2 knockdown cells were only partially sensitive to amino acid starvation [ Fig. 1 , E (compare lanes 2 and 8) and F (compare black bars with gray bars)], as previously reported (23) (24) (25) . Although PIP4kg knockdown did not affect mTORC1 activity in Tsc2 knockdown cells growing in complete medium, it significantly decreased mTORC1 signaling in starved cells [ Fig. 1 , E (compare lanes 2 and 5) and F (compare black bars with white bars), and fig. S1 , B and C]. Phosphorylation of p70S6K was two-to threefold lower in the Tsc2 and PIP4kg knockdown cells starved of glucose and glutamine or amino acids, as compared to cells in which only Tsc2 was knocked down. PIP4kg knockdown in amino acidor serum-starved cells also decreased the phosphorylation of S6 and increased the electrophoretic mobility of p70S6K and S6 proteins, as compared to control cells, without affecting the total abundance of these proteins (Fig. 1 , A, C, and E, and fig. S1C ). Furthermore, unphosphorylated 4E-BP was fourfold more abundant in amino acid-starved cells with knockdown of both Tsc2 and PIP4kg compared to those with knockdown of only Tsc2 (Fig. 1, E and F) . The basal mTORC1 activity in amino acid-starved cells with knockdown of both Tsc2 and PIP4kg was similar to that in cells with normal Tsc2 expression [ Fig. 1 , E (compare lanes 5 and 8) and F]. These results indicated that PIP4kg knockdown impaired mTORC1 signaling during starvation.
To confirm that PIP4kg promotes basal TORC1 signals that regulate protein translation in starved cells, we examined the effect of PIP4kg knockdown on 4E-BP association with eIF4E in HeLa cells with normal Tsc2 expression. When these cells were starved of glucose and glutamine, unphosphorylated 4E-BP associated with eIF4E (Fig. 1G) . Upon nutrient stimulation, 4E-BP dissociated from the complex, allowing eIF4G and eIF4A to be recruited. In starved cells, knockdown of PIP4kg increased the abundance of unphosphorylated 4E-BP and the ratio of 4E-BP/eIF4G bound to the m7GTP beads, suggesting a decrease in basal mTORC1 activity and a reduction in the formation of active translation initiation complexes (Fig. 1, G and H) . Together, these results demonstrated that PIP4kg increased basal TORC1 signaling to regulate protein translation and cell mass.
PIP4kg is phosphorylated downstream of mTORC1
PIP4kg exists in multiple phosphorylated forms with distinct electrophoretic mobilities (13, 26) . Treatment with phosphatases results in a shift in the PIP4kg electrophoretic mobility to a single fast-mobility form (13, 26) . While examining the abundance of endogenous and exogenous PIP4kg in HeLa and BTC6 mouse insulinoma cells, we observed that, upon glucose and glutamine starvation, the abundance of the slowly migrating forms (upper bands) of PIP4kg decreased, whereas that of the more quickly migrating form (bottom band) increased ( Fig. 2A) . Amino acid and glucose starvation were most effective at promoting a shift in PIP4kg mobility from the upper to the lower form, suggesting that PIP4kg is phosphorylated by mTORC1 ( fig. S1C ). To test this possibility, we compared the electrophoretic mobility of PIP4kg in wild-type and Tsc2 knockout cells. The ratio of slow/fast PIP4kg was higher in Tsc2 -/-mouse embryonic fibroblasts (MEFs) than in MEFs from wild-type mice (Fig. 2B) , and also higher in HeLa cells with Tsc2 knockdown (Fig. 1A , compare lanes 1 and 2). Inhibition of mTORC1 with rapamycin or Ku0063794 resulted in a shift in PIP4kg mobility from the slow to the fast form (Fig. 2 , B and C). Changes in PIP4kg mobility in these cells resembled those in the mobility of p70S6K, a bona fide TORC1 substrate (15, 27) . In contrast, PIP4kg mobility was not affected by treatment with staurosporine ( Fig. 2B) , an AGC kinase inhibitor that inhibits the activity of p70S6K but not that of mTORC1 (28) . Thus, PIP4kg was modified downstream of mTORC1, independently of p70S6K activity. P incorporation into GST-PIP4kg, WT, or mutant (S328A) or PIP4kb and mTOR autophosphorylation. Wortmannin was used to inhibit mTOR activity. n = 2 independent experiments. treated or not with rapamycin. We identified Ser 328 as a rapamycin-sensitive phosphorylation site ( fig. S1D ), which is consistent with the shift in PIP4kg electrophoretic mobility, given that Ser 328 is followed by a proline residue ( fig. S1E ) and the phosphorylation of serine residues adjacent to proline causes substantial shifts in electrophoretic mobility due to proline isomerization (29) .
On the basis of comparison of the PIP4kg sequence with other mTORC1 substrates (30, 31), we predicted that Ser 324 was an mTORC1-dependent phosphorylation site. This site was not covered by the LC-MS/MS analyses. To test whether Ser 324 and Ser 328 were phosphorylated by mTORC1, we expressed forms of myc-PIP4kg that were wild type or had single S328A or double S324/328A mutations in Tsc2 -/-MEFs. A form of PIP4kg with a mutation in the predicted catalytic lysine (K152A) (32) was used to rule out autophosphorylation. Metabolic labeling of these cells with 32 P showed that wild-type PIP4kg is highly phosphorylated in a rapamycin-sensitive manner (Fig. 2D) . Phosphorylation of PIP4kg was almost completely abolished by the S324/328A double mutation and partially inhibited by the single S328A mutation. To confirm that the more slowly migrating bands were phosphorylated forms of PIP4kg, we compared the electrophoretic mobility of the different mutants (Fig. 2, E and F) . Although 85 to 90% of wild-type PIP4kg migrated with slower mobility (upper band), the double mutant S324/328A migrated as a single faster band (lower band), regardless of whether mTORC1 was active or inhibited by rapamycin treatment. The single S328A mutation partially suppressed the PIP4kg slow mobility band. These results confirmed that Ser 324 and Ser 328 are mTORC1-dependent phosphorylation sites and that the different electrophoretic mobility bands correspond to PIP4kg phosphorylated at one or both mTORC1 sites.
Ser 324 and Ser 328 reside within the kinase insert region of PIP4kg ( fig. S1E ). Sequence alignment between the kinase insert regions of all three PIP4k isoforms indicated that Ser 324 is conserved only in the b and g isoforms, and Ser 328 is unique to the g isoform. Because this region of PIP4kb is a substrate for the MAPK p38 (11) and PIP4ka is a substrate for PKD (12), we tested the role of these kinases on PIP4kg phosphorylation. PIP4kg mobility was not affected by the p38 inhibitor SB203580 or the PKD inhibitor Go6983 ( fig. S1F ), demonstrating that mTORC1-mediated phosphorylation of PIP4kg does not require priming by these kinases.
To address whether mTOR can directly phosphorylate PIP4kg, we incubated purified GST (glutathione S-transferase)-PIP4kg with purified mTOR and [g-32 P]ATP. This resulted in 32 P labeling of a 130-kD band corresponding to the autophosphorylation of recombinant mTOR, and a 70-kD band corresponding to the GST-PIP4kg (Fig. 2G) . Addition of the mTOR inhibitor wortmannin (33) abolished the appearance of these bands, thus confirming that the labeled bands were indeed phosphorylation products of mTOR and indicating that PIP4kg is a substrate for mTOR.
mTORC1 associates with PIP4kg
The mTORC1 regulatory subunit Raptor associates with many mTORC1 substrates through their TOS (TOR signaling) motif, an interaction that is critical for the phosphorylation of its substrates (21) . Rapamycin inhibits mTORC1 partly because it destabilizes the association between mTOR and Raptor (34) . To examine whether Raptor interacts with PIP4kg, we immunoprecipitated Raptor from lysates of Tsc2 -/-MEFs expressing myc-PIP4kg. Raptor immunoprecipitates contained PRAS40, an mTORC1 substrate and binding partner, as well as the slow-and faster-migrating forms of myc-PIP4kg (Fig. 3A) . To show that Raptor associated with endogenous PIP4kg, we used BTC6 cells because endogenous PIP4kg is more abundant in these cells than in HeLa cells or MEFs (Fig. 2A) . Raptor immunoprecipitates contained a PI-5-P 4-kinase activity, consistent with the association of PIP4k with Raptor (Fig. 3B) . To test whether PIP4kg interacts with mTOR, we immunoprecipitated myc-PIP4kg from lysates of Tsc2 -/-MEFs expressing wild-type or kinase-inactive myc-PIP4kg. PIP4kg associated with a protein kinase capable of phosphorylating it, an association that was partially decreased in cells treated with rapamycin (Fig. 3, C and  D) . Rapamycin did not affect myc-PIP4kg association with Raptor (Fig. 3A) , but it partially decreased the association with mTOR (Fig. 3, C and D) , suggesting that Raptor interacts directly with PIP4kg. The ability of Ku0063794 to disrupt the interaction between Raptor and endogenous PI-5-P 4-kinase activity (Fig. 3B) was surprising. We speculate that the association of PIP4kg with mTOR (an enzyme/substrate interaction) strengthens its association with Raptor, but in the presence of the catalytic inhibitor Ku0063794 (35) , this complex is disrupted. Together, these results show that PIP4kg can associate with mTORC1. Because the TOS motif is not easily identifiable through sequence analysis, deletion studies will be necessary to confirm that PIP4kg has a TOS motif.
Phosphorylation of PIP4kg increases its affinity for cytoplasmic vesicles
Unlike other mTORC1 substrates, phosphorylation of PIP4kg did not affect protein stability or associated PI-5-P 4-kinase activity ( fig. S2 , A to C). Furthermore, the phosphorylation state of PIP4kg did not affect its homo-or heterodimerization or cellular PI-5-P amounts ( fig. S2, B to D) . Therefore, we set out to determine whether mTORC1-dependent phosphorylation plays a role in the subcellular distribution of PIP4kg. PIP4kg localizes to cytoplasmic vesicles and vesicles associated with the Golgi (5, 13, 36). Immunocytochemistry of BTC6 and HeLa cells confirmed that endogenous PIP4kg localizes to vesicular compartments in these cells ( fig. S3 ). PIP4kg-containing vesicles were either spread throughout the cytoplasm, surrounding the nucleus, or associated with the Golgi. To examine the phosphorylation state of PIP4kg in these vesicular compartments in a quantitative manner, we used a differential centrifugation protocol that generates four subcellular fractions enriched in cytosol, light microsomal membranes, heavy microsomal membranes, and membranes associated with the nucleus. Immunoblotting for various organelle markers showed that most organelles and membrane compartments, including mitochondria [marker: ATP (adenosine 5′-triphosphate) synthase], plasma membrane (marker: b 1 integrin), ER [marker: protein disulfide isomerase (PDI)], Golgi (marker: GM130), and lysosome (marker: Lamp1), sedimented with the heavy microsomal fraction and the membranes associated with the nucleus (Fig. 3E  and fig. S4, A to D) . The light microsomal fraction contained intracellular vesicles containing COPI (marker: bCOP) and COPII (marker: Sec23), but virtually no Golgi, ER, mitochondria, or plasma membrane. Although PIP4kg was present in all four fractions, it was enriched in the light microsomal fraction (Fig. 3F) together with bCOP-and Sec23-containing vesicles, consistent with the staining of PIP4kg in small cytoplasmic vesicles ( fig. S3, A to V) . The light microsomal fraction contained predominantly the phosphorylated form of PIP4kg, whereas the heavy microsomal fraction, which includes the Golgi, contained almost exclusively the unphosphorylated form (Fig. 3F, compare lanes 2 and 3, and fig. S4E , compare dark bars with light bars). These data suggested that the distribution of the different phosphorylation states of PIP4kg is compartmentalized.
To further examine how TORC1-mediated phosphorylation affected PIP4kg localization, we generated BTC6 cell lines in which the expression of PIP4kg is under the control of a doxycycline-inducible promoter. Exogenous wild-type PIP4kg localized predominantly to the light microsomal fraction, a distribution that was decreased by rapamycin treatment (Fig. 3,  G and H) . The distribution of a phosphorylation-mimetic mutant (S324/ 328D) resembled that of wild-type PIP4kg, whereas the phosphorylationdefective mutant S324/328A resembled that of rapamycin-treated cells with decreased localization in the light microsomal fraction (Fig. 3, G and H) , suggesting that phosphorylation determines whether PIP4kg concentrates on light vesicles. Upon overexpression, PIP4kg abundance in the heavy microsomal fraction did not increase proportionally to its overall increase in expression (compare Fig. 3F with Fig. 3G ), suggesting that localization to this compartment is saturable or limited by a cellular component. Nonetheless, the percentage of PIP4kg in the heavy microsomal fraction was twofold higher for the S324/328A mutant than for wild-type (Fig. 3,  G and H) . As expected, the localization of the phosphorylation-defective mutant was not affected by rapamycin (fig. S4, G and H) . Together, these results demonstrated that unphosphorylated PIP4kg cofractionated with the Golgi in the heavy microsomal fraction, whereas phosphorylated PIP4kg was enriched in the light cytosolic vesicles. This compartmentalization raises the possibility that the phosphorylated and unphosphorylated PIP4kg could have distinct functions in cells.
Unphosphorylated PIP4kg increases mTORC1 signaling
The ability of PIP4kg to regulate mTORC1 was enhanced during nutrient starvation when the abundance of the unphosphorylated form of PIP4kg was enhanced ( Fig. 2A and fig. S1C ). These data suggested that phosphorylation inhibits the ability of PIP4kg to regulate mTORC1. To investigate how the different phosphorylation states of PIP4kg affect mTORC1 signaling, we expressed wild-type PIP4kg, phosphorylationdefective (S324/328A), or phosphorylation-mimetic (S324/328D) mutants in HeLa cells using a doxycycline-inducible promoter. The S324/328D mutant protein had the same electrophoretic mobility as the more slowly migrating band of wild-type protein, whereas the S324/328A had the same electrophoretic mobility as the more rapidly migrating band (Fig. 4A) . Unlike wild-type PIP4kg, the electrophoretic mobility of the mutant proteins was not affected by serum or amino acid starvation. In nutrient-deprived cells expressing wild-type PIP4kg, the unphosphorylated form of the kinase was predominant over the phosphorylated form, and basal mTORC1 signaling was enhanced in a dose-responsive manner (Fig. 4, B and C) . Phosphorylation of p70S6K was increased by expression of the S324/ 328A mutant and decreased by expression of the S324/328D mutant in nutrient-deprived cells (Fig. 4, B and C) . The effect of mutant PIP4kg on mTORC1 activity demonstrated that unphosphorylated PIP4kg promotes basal mTORC1 activation and that phosphorylation counteracts this function of PIP4kg.
DISCUSSION
mTORC1 signaling regulates many complex cellular processes including cell proliferation, cell size, and autophagy. mTORC1-mediated regulation of cell size can be partially attributed to its ability to stimulate protein translation through phosphorylation of p70S6K and 4E-BP. Here, we identified PIP4kg as a substrate for mTORC1 involved in the regulation of cell size. We found that PIP4kg knockdown impaired mTORC1 signaling in starved cells, but not in cells growing in complete medium, suggesting a specific role for PIP4kg in maintaining basal mTORC1 signaling. Thoreen and collaborators determined that acute inhibition of mTORC1 significantly suppressed the translation of a subset of mRNAs with 5′ terminal oligopyrimidine (TOP) motifs (37) . Many components of the translational machinery, such as ribosomes and initiation factors, are TOP-containing mRNAs regulated by mTORC1 signaling. We speculate that PIP4kg-mediated mTORC1 activation is an important mechanism to maintain the basal abundance of the components of the translational machinery necessary to restart translation once ATP and amino acid stores are replenished. PIP4kg's long half-life (about 10 hours; fig. S2A ) makes it a suitable regulator of basal protein translation during nutrient starvation. We demonstrated that the ratio between the phosphorylated and unphosphorylated forms of PIP4kg depends on the activity of mTORC1. In starved cells, PIP4kg is predominantly in the unphosphorylated state and participates in the activation of mTORC1. When ATP and amino acids are abundant and mTORC1 is fully active, phosphorylated PIP4kg becomes the predominant form, which cannot activate mTORC1 (Fig. 4D) . This negative feedback loop could be a mechanism for keeping basal mTORC1 activity low and tightly regulated. However, it is possible that in cancer cells, this negative feedback loop is disrupted, allowing them to grow in low nutrients. PIP4kg's role in activating mTORC1 in nutrient-deprived cells seems contrary to the role of LKB1 (liver kinase B1), a tumor suppressor kinase that inhibits mTORC1 activity through phosphorylation of AMPK [AMP (adenosine 5′-monophosphate)-dependent kinase] when ATP concentrations are low (38) . However, it is unlikely that PIP4kg-mediated activation of mTORC1 in its basal state is mediated by inhibition of AMPK signaling, given that HeLa cells are deficient in LKB (39) and have impaired inactivation of mTORC1 in response to AMPK activation (40) .
On the basis of the ability of mTORC1 to phosphorylate PIP4ks in vitro and the sequence similarity of the mTORC1-dependent phosphorylation sites on PIP4kg to those in other mTORC1 substrates, we propose that PIP4kg is a direct substrate for mTORC1. The two mTORC1-dependent phosphorylation sites that we identified reside in proximity to each other in the kinase insert region of PIP4kg. This region of the protein is highly disordered and protrudes away from the rest of the enzyme (7). Thus, it is not completely surprising that phosphorylation by mTORC1 did not affect the low intrinsic lipid kinase activity of PIP4kg or the activity of the associated a and b isoforms. Instead, we found that unphosphorylated PIP4kg is preferentially localized at the Golgi, whereas the phosphorylated form is preferentially at light cytoplasmic vesicles. The a, b, and g isoforms of PIP4k can form heterodimers [ fig. S2B and (7, 41) ] (Thorsell et al., unpublished structure PDB entry 2GK9), and PIP4kg has been suggested to serve as a chaperone for the more active a and b isoforms (36) . Therefore, the subcellular localization of PIP4kg is likely to determine sites of active PI-5-P consumption and PI(4,5)P 2 synthesis. Because PI(4,5)P 2 participates in actin rearrangement and membrane trafficking events such as vesicle budding, docking, and fusion (42), we propose that the PI-5-P 4-kinase activity associated with PIP4kg plays a role in the trafficking of a population of Golgi-derived vesicles. We envision that PIP4kg cycles between the Golgi, the cytoplasmic vesicles, and the cytosol. In our model, unphosphorylated PIP4kg exits the Golgi in Golgi-derived vesicles, where it becomes phosphorylated by mTORC1. Upon mTORC1 inhibition, dephosphorylated PIP4kg dissociates from these vesicles into the cytosol, where it may be recruited back to the Golgi. Live cell imaging of PIP4kg will help confirm this model.
The mechanism by which PIP4kg regulates basal mTORC1 activity is not entirely clear. Activation of the small GTPase (guanosine triphosphatase) Rheb by inhibition of Tsc2 (a GTPase-activating protein for Rheb) is indispensable for mTORC1 activation in response to all stimuli (25) . In addition, it is critical that mTOR is transported to intracellular membrane compartments where Rheb is present (43, 44) . Amino acid-dependent activation of mTORC1 occurs at the surface of the lysosomes (45) . However, it is likely that additional sites of mTORC1 activation exist, given that Rheb resides in various intracellular compartments (25, 44) . PI kinases can control mTOR localization and activity. For example, the phosphatidylinositol-3-phosphate 5-kinase PIKFYVE and the class II phosphatidylinositol 3-kinase (PI3K)-CIIa activate mTORC1 through the generation of PI(3,5) P 2 at the plasma membrane (46) , and the endosomal class III PI3K hVps34 activates mTORC1 in a nutrient-dependent manner (47) . The subcellular distribution of PIP4kg suggests a role for the PI-5-P pathway in the synthesis of PI(4,5)P 2 for Golgi-mediated intracellular membrane trafficking. Furthermore, our results show that PIP4kg can associate with mTORC1, which is also found at the Golgi (48) . Thus, we propose that during nutrient starvation, PIP4kg facilitates mTORC1 transport to sites where active Rheb is present. Future studies will seek to identify the mechanisms by which PIP4kg and the PI-5-P pathway for PI(4,5)P 2 synthesis contribute to vesicle trafficking events that modulate mTORC1 signaling.
MATERIALS AND METHODS
Cell lines, maintenance, and manipulations
HeLa and BTC6 cells were from the American Type Culture Collection. MEF cells were a gift from B. Manning (Harvard Medical School). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM; CellGro Mediatech Inc.) supplemented with 10% fetal bovine serum (FBS). Transfections were performed with TransPass D1 (New England BioLabs) or Lipofectamine Plus (Invitrogen) according to the manufacturer's protocols. For stable expression of recombinant PIP4kg and knockdowns, we used retroviral and lentiviral delivery systems. Viruses were generated by transiently transfecting 293T cells with the appropriate expression plasmid and packing plasmids. Stable knockdown cells were generated by infection with pSuper. retro.puro and/or pReSi-derived retrovirus carrying the target sequence for PIP4kg or a control sequence, which contained the target sequences with four to six bases mismatched, or with pMSCV carrying the target sequence for Tsc2 or luciferase, as a control. Transient knockdowns were obtained by transfection with 125 pmol of the small interfering RNA targeting PIP4kg, PIP4kb, or a control sequence (see above) using Lipofectamine 2000 (Invitrogen). For transient expression of myc-PIP4kg, we used pCMV vector. For stable expression of untagged PIP4kg, we used pLXSN (high expression) and pLVX-Tight-puro tet-inducible (Clontech) vectors. Doxycycline was used at 0.007 to 0.5 mg/ml. For nutrient starvation experiments, cells were kept in DMEM deprived of glucose and glutamine (Gibco) for 3 to 5 hours. For amino acid starvation experiments, cells were kept in Dulbecco's phosphate-buffered saline (PBS) supplemented with CaCl 2 , MgCl 2 , sodium pyruvate, and glucose for 60 to 90 min. For nutrient deprivation experiments, cells were collected 72 hours after addition of fresh medium. For nutrient restimulation experiments, 25 mM glucose and 4 mM L-glutamine were added to the medium. Rapamycin was used at 20 nM, staurosporine at 0.1 mM, SB203580 at 1 mM, Go6976 at 0.5 mM, Go6983 at 0.25 mM, and Ku0063794 at 1 mM. Cells were treated with these inhibitors for 2 to 4 hours, with the exception of the cell size experiments, in which cells were treated with rapamycin for 24 hours.
Immunoprecipitation and Western blot analysis
Total protein lysates were obtained by lysing cells in buffer containing 50 mM tris-HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1% Triton X-100, and 10% glycerol, as well as protease (Sigma) and phosphatase inhibitors [1 mM sodium orthovanadate, sodium fluoride (2 mg/ml), and b-glycerophosphate (2 mg/ml)]. Lysates were centrifuged at 14,000g to remove the insoluble fraction and were normalized on the basis of total protein content measured by Bradford assay (Bio-Rad). For immunoprecipitations, antibody was added to the cell lysate and incubated for 2 hours at 4°C. Protein A or protein G-Sepharose beads (Amersham) were then added to the lysates and incubated for 1 hour at 4°C. Lysates were centrifuged and Sepharose beads were washed three times in lysis buffer. Total cellular protein or immunoprecipitates were mixed with SDS loading buffer, boiled for 5 min, and separated by 10% or by 4 to 20% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (Bio-Rad). For separation of the phosphorylated forms of PIP4k and p70S6k, electrophoresis was carried out on a 15-cm gel. Proteins were transferred onto nitrocellulose membrane, which was blocked with 5% milk in tris-buffered saline (TBS) plus 1 mM sodium orthovanadate. Membranes were probed overnight at 4°C with the appropriate primary antibody. After washing, membranes were incubated for 60 min at room temperature with secondary antibodies conjugated to IR680 (Rockland and Molecular Probes) or IR800 (Rockland). The membranes were washed in TBS-Tween, and bound antibodies were detected and quantified using the Odyssey Infrared Imaging System (LI-COR). Antibodies against tubulin were from BD Transduction Laboratories. Antibodies against phosphorylated p70S6k, total p70S6k, phosphorylated S6, total S6, total and unphosphorylated 4E-BP, Raptor, eIF4G, and eIF4E were from Cell Signaling Technology. Raptor antibody for immunoprecipitation was from Millipore. Antibody against PIP4kb was a gift from M. Chao or purchased from Cell Signaling Technology, and antibody against PIP4kg was raised in rabbits against a GST-PIP4kg N-terminal fusion protein.
Measurements of unphosphorylated 4E-BP
Protein lysates were prepared as described above. The abundance of unphosphorylated 4E-BP was measured by Western blot of total lysates using an antibody specific to the unphosphorylated form of 4E-BP (anti-non-phospho-4E-BP), which recognizes the mTORC1-dependent target site in 4E-BP (Thr 46 ) only when in its unphosphorylated form (Cell Signaling Technology). The amounts of eIF4E-associated 4E-BP were measured using m7GTP-Sepharose beads in a pulldown assay. In this assay, protein lysates were normalized for protein content and incubated with m7GTP beads (GE Healthcare) for 3 hours. The beads were washed in lysis buffer, and the associated proteins were analyzed by Western blot using antibody against 4E-BP, eIF4E, or eIF4G (Cell Signaling Technology).
In vivo phosphorylation assay
Tsc2
−/− MEFs were transiently transfected with myc-PIP4kg, wild type, or mutants, and then labeled with inorganic 32 P (0.2 mCi/ml) (PerkinElmer) in phosphate-free DMEM supplemented with 10% dialyzed FBS for 3 hours before lysis. Exogenous PIP4kg was immunoprecipitated using anti-myc antibody (Millipore), as described above. After electrophoresis, gels were stained with Coomassie, dried, and exposed to film.
PI-5-P 4-kinase assay
Immunoprecipitates were incubated with 200 mM PI-5-P/phosphatidylserine (1:5) and 1 mCi [ 
Subcellular fractionation by differential centrifugation
Cells were washed in PBS, rinsed with cytosol buffer [0.2 M sucrose, 25 mM Hepes (pH 7), 125 mM potassium acetate, 1 mM dithiothreitol (DTT), 1 mM sodium orthovanadate, sodium fluoride (2 mg/ml), b-glycerophosphate (2 mg/ml), 1 mM phenanthroline, 1 mM benzamidine, and protease inhibitor cocktail from Sigma], and scraped from the dish. The cell suspension was passed through a 29 ½-gauge needle 12 times and centrifuged at 100g for 10 min to obtain a pellet containing nuclei, nuclei-associated membranes, and unbroken cells (about 5% of total cells, as determined by trypan blue staining). The supernatant from this spin (microsomal fraction) was centrifuged at 16,000g for 30 min to pellet the heavy microsomes. The supernatant from this step was further centrifuged for 45 min at 400,000g in a TL100 centrifuge using a TLA120.2 rotor (Beckman) to separate the light microsomes from the cytosol. All pellets were resuspended in cytosol buffer containing 1% Triton X-100 and centrifuged at 14,000g for 10 min (in the case of the nuclear and heavy microsomal pellet) to remove any tritoninsoluble material. Fractions were normalized for cell number, mixed with SDS-containing loading buffer, and resolved by SDS-PAGE. Western blot analysis of the different fractions used antibodies against the following organelle markers: anti-GM130 (BD Biosciences) for Golgi, anti-KDEL (Stressgen) for ER, anti-bCOP (ABR or Sigma) for COPI vesicles, anti-Sec23 (Santa Cruz Biotechnology) for COPII vesicles, anti-Lamp1 (Cell Signaling Technology) for lysosomes, and anti-b 1 integrin (BD Biosciences) for plasma membrane.
Immunostaining
Cells were plated on 25-mm glass coverslips, cultured for 1 to 2 days, and fixed in cold methanol or 4% paraformaldehyde at 4°C for 10 min, followed by treatment with 0.2% Triton/PBS. Coverslips were blocked in saline buffer containing 10% donkey serum for 1 hour, incubated overnight at 4°C with primary antibody, and then incubated for 1 hour at room temperature in donkey anti-IgG (immunoglobulin G) antibody conjugated with Cy2, Cy3, or Cy5 and DAPI (4′,6-diamidino-2-phenylindole). Coverslips were mounted in Fluoromount-G (SouthernBiotech), and cells were imaged using a Leica SPF5 confocal microscope.
Metabolic labeling of PIs
Cells were metabolically labeled at 37°C with [ 3 H]inositol (10 mCi/ml) (ARC) for 24 to 72 hours in inositol-free DMEM supplemented with dialyzed fetal calf serum (Gibco) and 4 mM L-glutamine (Invitrogen).
High-performance liquid chromatography method for PI analysis Cellular PIs were extracted and deacylated as described (49) . Deacylated lipids were separated by anionic-exchange HPLC (high-performance liquid chromatography) (Agilent 1200) using two PartiSphere SAX columns (Whatman) in tandem and a four-step gradient of ammonium phosphate (pH 6.0) (1 to 4 mM over 60 min; 4 to 15 mM over 5 min; 15 mM isocratic for 20 min; and 15 to 65 mM over 25 min). Radiolabeled eluates were detected by an online flow scintillation analyzer (PerkinElmer) and quantified using ProFSA software (PerkinElmer).
mTOR kinase assay and PIP4kg-associated kinase assay For Fig. 2G , GST-PIP4kb and GST-PIP4kg were expressed in bacteria and purified using GSH (glutathione)-Sepharose beads. Recombinant mTOR was purchased from Calbiochem. For Fig. 3C , myc-PIP4kg was immunoprecipitated with an anti-myc antibody, as described above. Purified PIP4k and/or mTOR or immunoprecipitates were incubated for 10 min in kinase buffer [50 mM tris (pH 7.5), 100 mM NaCl, 10 mM MnCl 2 , 1 mM DTT, 10 mM ATP] with 10 mCi of [g- 32 P]ATP (PerkinElmer) at 37°C. Wortmannin was used at 1 mM to inhibit mTOR. The reaction was stopped by addition of SDS-containing loading buffer and was subjected to SDS-PAGE. The gel was dried, and the radioactivity was detected using a Storm PhosphorImager and film.
Flow cytometric analysis of cell size
For cell size experiments, HeLa cells were seeded in six-well plates at a density of 1.5 × 10 5 cells per well and cultured overnight. The next day, medium was replaced with serum-free medium with or without 20 nM rapamycin as a control. After 24 hours of treatment, cells were processed for flow cytometry. Briefly, cells were lifted from the plate by trypsinization, centrifuged, and resuspended in 0.3 ml of PBS and fixed overnight at 4°C in 70% cold ethanol. Fixed cells were centrifuged at 1000 rpm for 5 min, washed once with PBS, and then incubated at 37°C for 1 hour in RNase (ribonuclease) A (0.2 mg/ml in PBS). Propidium iodide was added to the cells at a concentration of 10 mg/ml immediately before analysis. DNA content and cell size were assessed using a BD FACSCalibur flow cytometer. Data were analyzed using CellQuest software. Single cells were selected using FL2-width versus FL2-area dot plot, and 10,000 cells were acquired. To measure relative cell size, mean forward scatter (FSC-H) of cells in G 1 phase of the cell cycle population was determined.
Liquid chromatography-tandem mass spectrometry
For all MS experiments, PIP4kg immunoprecipitates were separated using SDS-PAGE, the gel was stained with Coomassie blue, and the PIP4kg band was excised. Samples were subjected to reduction with DTT, alkylation with iodoacetamide, and in-gel digestion with trypsin or chymotrypsin overnight at pH 8.3, followed by reversed-phase microcapillary/LC-MS/MS. LC-MS/ MS was performed with an EASY-nLC nanoflow HPLC (Thermo Fisher Scientific) with a self-packed 75-mm id (internal diameter) × 15-cm C 18 column connected to a hybrid linear ion trap LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientific) in the data-dependent acquisition and positive ion mode at 300 nl/min. MS/MS spectra collected through collisioninduced dissociation in the ion trap were searched against the concatenated target and decoy (reversed) Swiss-Prot and PIP4kg single-entry protein databases using Sequest with differential modifications for Ser/Thr/Tyr phosphorylation (+79.97) and the sample processing artifacts Met oxidation (+15.99), deamidation of Asn and Gln (+0.984), and Cys alkylation (+57.029) as affixed modification. Phosphorylated and unphosphorylated peptide sequences were identified if they initially passed the following Sequest scoring thresholds against the target database: 1+ ions, Xcorr ≥ 2.0 Sf ≥ 0.4, P ≥ 5; 2+ ions, Xcorr ≥ 2.0, Sf ≥ 0.4, P ≥ 5; 3+ ions, Xcorr ≥ 2.60, Sf ≥ 0.4, P ≥ 5 against the target protein database. Passing MS/MS spectra were manually inspected to be sure that all b-and y-fragment ions aligned with the assigned sequence and modification sites. Determination of the exact sites of phosphorylation was aided using FuzzyIons and GraphMod software (Proteomics Browser Software suite, Harvard University). False discovery rates of peptide hits were estimated below 1.2% based on reversed database hits.
Statistical analysis
Bar graphs show the mean and SEM. P values were calculated using paired two-tailed Student's t test of the data before normalization (Fig. 1, B and D) or of the data normalized against a third set of data used as reference (Figs. 1,  F and H, 3D, and 4C and fig. S2D ). For distribution analysis, P values were calculated using two-sample, equal-variance, two-tailed t test (Fig. 2F, 3H , and fig. S4 ). P values less than or equal to 0.05 were considered statistically significant.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/7/350/ra104/DC1 Fig. S1 . PIP4kg knockdown decreases cell size and mTORC1 signaling in serum-or amino acid-starved Tsc2 knockdown cells and identification of mTORC1-dependent phosphorylation sites in PIP4kg. Fig. S2 . Phosphorylation of PIP4kg does not affect protein stability, dimerization, or associated kinase activity or cellular PI-5-P. Fig. S3 . PIP4kg localizes to cytosolic and Golgi-associated vesicles. Fig. S4 . Analysis of the effect of rapamycin on the distribution of PIP4kg, GM130, or bCOP among the four fractions generated by differential centrifugation of BTC6 cells.
